Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 9 | 2018 | 22 | 1.690 |
Why?
|
| Surgical Mesh | 11 | 2014 | 26 | 1.530 |
Why?
|
| Herniorrhaphy | 9 | 2018 | 37 | 1.440 |
Why?
|
| Postoperative Complications | 20 | 2018 | 930 | 1.180 |
Why?
|
| Hernia, Inguinal | 7 | 2016 | 22 | 1.180 |
Why?
|
| Obesity, Morbid | 2 | 2017 | 102 | 0.990 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 145 | 0.950 |
Why?
|
| Laparoscopy | 13 | 2016 | 199 | 0.920 |
Why?
|
| Esophageal Neoplasms | 7 | 2002 | 53 | 0.850 |
Why?
|
| Stomach Neoplasms | 3 | 2016 | 35 | 0.700 |
Why?
|
| General Surgery | 4 | 2015 | 56 | 0.600 |
Why?
|
| Middle Aged | 42 | 2018 | 9186 | 0.550 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2015 | 36 | 0.550 |
Why?
|
| Gastroplasty | 1 | 2016 | 28 | 0.530 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 28 | 0.510 |
Why?
|
| Aged | 31 | 2018 | 9222 | 0.500 |
Why?
|
| Male | 45 | 2020 | 15143 | 0.490 |
Why?
|
| Gastric Bypass | 1 | 2016 | 70 | 0.490 |
Why?
|
| Carcinoma | 3 | 2016 | 69 | 0.480 |
Why?
|
| Treatment Outcome | 22 | 2018 | 3530 | 0.460 |
Why?
|
| Humans | 60 | 2020 | 28054 | 0.440 |
Why?
|
| Educational Measurement | 3 | 2015 | 60 | 0.440 |
Why?
|
| Adult | 30 | 2018 | 8021 | 0.430 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2003 | 24 | 0.430 |
Why?
|
| Recurrence | 10 | 2017 | 318 | 0.430 |
Why?
|
| Female | 42 | 2018 | 15534 | 0.420 |
Why?
|
| Quality Improvement | 4 | 2014 | 160 | 0.410 |
Why?
|
| Retrospective Studies | 25 | 2018 | 3524 | 0.400 |
Why?
|
| Hepatectomy | 6 | 2015 | 64 | 0.400 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 61 | 0.400 |
Why?
|
| Liver Neoplasms | 5 | 2000 | 105 | 0.380 |
Why?
|
| Esophagectomy | 5 | 2002 | 24 | 0.380 |
Why?
|
| Colectomy | 3 | 2016 | 23 | 0.370 |
Why?
|
| Curriculum | 2 | 2003 | 152 | 0.360 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 6 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 5 | 2013 | 98 | 0.330 |
Why?
|
| Aged, 80 and over | 13 | 2017 | 4846 | 0.290 |
Why?
|
| Students, Medical | 2 | 2013 | 50 | 0.290 |
Why?
|
| Risk Factors | 9 | 2018 | 2371 | 0.270 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2007 | 75 | 0.270 |
Why?
|
| Survival Rate | 9 | 2015 | 354 | 0.260 |
Why?
|
| Prospective Studies | 9 | 2014 | 1748 | 0.250 |
Why?
|
| Smoking | 2 | 2016 | 177 | 0.250 |
Why?
|
| Hernia, Hiatal | 2 | 2014 | 13 | 0.230 |
Why?
|
| Polypropylenes | 1 | 2003 | 2 | 0.220 |
Why?
|
| Gastrectomy | 3 | 2015 | 31 | 0.210 |
Why?
|
| Prognosis | 6 | 2017 | 818 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 1809 | 0.200 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2013 | 15 | 0.200 |
Why?
|
| Cholangiography | 4 | 2015 | 12 | 0.200 |
Why?
|
| Ultrasonography | 4 | 2020 | 232 | 0.200 |
Why?
|
| Laparotomy | 3 | 2020 | 19 | 0.190 |
Why?
|
| Colorectal Neoplasms | 4 | 1997 | 113 | 0.190 |
Why?
|
| Hernia, Femoral | 1 | 2001 | 1 | 0.190 |
Why?
|
| United States | 9 | 2016 | 2155 | 0.180 |
Why?
|
| Mesenteric Cyst | 1 | 2020 | 2 | 0.180 |
Why?
|
| Lymphokines | 1 | 2000 | 8 | 0.170 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 8 | 0.170 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 9 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2020 | 67 | 0.170 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 39 | 0.170 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 36 | 0.170 |
Why?
|
| Peritoneum | 2 | 2003 | 16 | 0.170 |
Why?
|
| Adolescent | 6 | 2007 | 2289 | 0.170 |
Why?
|
| Suture Techniques | 3 | 2007 | 155 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1997 | 177 | 0.160 |
Why?
|
| Pneumonia | 2 | 2016 | 77 | 0.160 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 87 | 0.160 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2018 | 4 | 0.160 |
Why?
|
| Cholelithiasis | 1 | 1998 | 9 | 0.150 |
Why?
|
| Compartment Syndromes | 1 | 2018 | 9 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2018 | 17 | 0.150 |
Why?
|
| Cholecystectomy | 3 | 2013 | 18 | 0.150 |
Why?
|
| Gallstones | 1 | 1998 | 10 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 202 | 0.150 |
Why?
|
| Lipoma | 1 | 2017 | 6 | 0.150 |
Why?
|
| Survival Analysis | 6 | 2015 | 265 | 0.150 |
Why?
|
| Myoepithelioma | 1 | 2017 | 4 | 0.140 |
Why?
|
| Liver | 2 | 1997 | 163 | 0.140 |
Why?
|
| Internship and Residency | 3 | 2015 | 216 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2003 | 275 | 0.140 |
Why?
|
| Databases, Factual | 5 | 2016 | 353 | 0.140 |
Why?
|
| Trachea | 1 | 1997 | 46 | 0.140 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1996 | 4 | 0.140 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2017 | 55 | 0.130 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 8 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Portal Vein | 1 | 1996 | 47 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 1997 | 163 | 0.130 |
Why?
|
| Thrombosis | 1 | 1996 | 56 | 0.130 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 6 | 0.130 |
Why?
|
| Fundoplication | 2 | 2013 | 22 | 0.130 |
Why?
|
| Certification | 1 | 2015 | 49 | 0.120 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 7 | 0.120 |
Why?
|
| Organs at Risk | 1 | 2015 | 9 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2015 | 28 | 0.120 |
Why?
|
| Hospital Costs | 1 | 1996 | 63 | 0.120 |
Why?
|
| Radiation Oncology | 1 | 2015 | 14 | 0.120 |
Why?
|
| Liver Regeneration | 1 | 1995 | 25 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2017 | 434 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 70 | 0.120 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 5 | 0.120 |
Why?
|
| Neoplasm Staging | 5 | 2015 | 372 | 0.120 |
Why?
|
| Esophagus | 2 | 2012 | 64 | 0.120 |
Why?
|
| Logistic Models | 4 | 2016 | 395 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 16 | 0.120 |
Why?
|
| Safety | 2 | 2007 | 44 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 15 | 0.120 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 68 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Clinical Competence | 3 | 2013 | 242 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 38 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 39 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 121 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 319 | 0.110 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.110 |
Why?
|
| Pain, Postoperative | 3 | 2013 | 307 | 0.110 |
Why?
|
| Cholestasis | 1 | 1993 | 9 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2014 | 33 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 27 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 990 | 0.110 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 5 | 0.110 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 6 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 33 | 0.110 |
Why?
|
| Length of Stay | 5 | 2014 | 327 | 0.110 |
Why?
|
| Operative Time | 4 | 2014 | 93 | 0.110 |
Why?
|
| Abdominal Wall | 1 | 2013 | 7 | 0.110 |
Why?
|
| Stents | 1 | 1993 | 85 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 313 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 42 | 0.100 |
Why?
|
| Sarcoma | 1 | 2015 | 144 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 142 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 80 | 0.100 |
Why?
|
| Prosthesis Implantation | 2 | 2013 | 30 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 321 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 174 | 0.100 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 18 | 0.100 |
Why?
|
| Time Factors | 4 | 2014 | 1485 | 0.090 |
Why?
|
| Morbidity | 3 | 2014 | 57 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 27 | 0.090 |
Why?
|
| Reoperation | 5 | 2016 | 906 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2013 | 135 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 370 | 0.080 |
Why?
|
| Hernia, Abdominal | 1 | 2007 | 2 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2007 | 8 | 0.070 |
Why?
|
| Omentum | 1 | 2007 | 8 | 0.070 |
Why?
|
| Chicago | 2 | 2001 | 902 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 125 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 788 | 0.060 |
Why?
|
| Child | 3 | 2001 | 1407 | 0.060 |
Why?
|
| Sutures | 2 | 2003 | 50 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 30 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 511 | 0.060 |
Why?
|
| Algorithms | 2 | 2015 | 371 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 758 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1366 | 0.060 |
Why?
|
| Comorbidity | 2 | 2016 | 497 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 318 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 45 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 176 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 91 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 96 | 0.050 |
Why?
|
| Workload | 1 | 2001 | 33 | 0.050 |
Why?
|
| Models, Educational | 1 | 2001 | 35 | 0.050 |
Why?
|
| Bile | 1 | 2020 | 5 | 0.040 |
Why?
|
| Intraoperative Care | 2 | 1998 | 43 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 664 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 10 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 13 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 1201 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 14 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 69 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 90 | 0.040 |
Why?
|
| Endosonography | 1 | 1999 | 12 | 0.040 |
Why?
|
| Infant | 1 | 2001 | 566 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 678 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1999 | 4 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 206 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 207 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 10 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 1998 | 23 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 605 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1997 | 306 | 0.040 |
Why?
|
| Bronchial Neoplasms | 1 | 1997 | 5 | 0.040 |
Why?
|
| Groin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2017 | 14 | 0.040 |
Why?
|
| Thigh | 1 | 2017 | 31 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 52 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 89 | 0.040 |
Why?
|
| Pilot Projects | 2 | 1997 | 432 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 34 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 106 | 0.030 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 5 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 1996 | 1 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 1 | 0.030 |
Why?
|
| Mesenteric Veins | 1 | 1996 | 2 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1997 | 24 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 492 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2016 | 16 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 14 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 366 | 0.030 |
Why?
|
| Cost Savings | 1 | 1996 | 33 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 1 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 53 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cardia | 1 | 1995 | 2 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 130 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 14 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 15 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 100 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 137 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 102 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 129 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 103 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 74 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 475 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 97 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 336 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 1994 | 5 | 0.030 |
Why?
|
| Jejunum | 1 | 1994 | 12 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 640 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1994 | 28 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 225 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 156 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 146 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 66 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 245 | 0.030 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 5 | 0.030 |
Why?
|
| Rats | 1 | 1995 | 675 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 158 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 411 | 0.030 |
Why?
|
| Ileus | 1 | 2013 | 4 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 9 | 0.030 |
Why?
|
| Seroma | 1 | 2013 | 4 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 92 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 633 | 0.030 |
Why?
|
| Intraoperative Period | 3 | 1997 | 27 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 582 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 1999 | 474 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1882 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 655 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 23 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 25 | 0.020 |
Why?
|
| Blood Loss, Surgical | 2 | 1999 | 59 | 0.020 |
Why?
|
| Animals | 1 | 1995 | 3824 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 501 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2002 | 20 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 34 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 441 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cystadenoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1999 | 8 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 20 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1997 | 46 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1997 | 117 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 53 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1997 | 231 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 244 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1994 | 7 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 13 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 13 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 12 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 98 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 66 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 1181 | 0.010 |
Why?
|